ReviewDer Internist2022
[Practical use of digital health applications (DiGA) in internal medicine].
Review in Der Internist, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 17 citations in OpenAlex.
- Digital Catalysts for Noncommunicable Disease Prevention Serious Games and Gamified Applications: Framework Design Study.JMIR serious games · 2025Article
- [Digital health applications-What we should know as rheumatologists].Zeitschrift fur Rheumatologie · 2024Review
- Applicability of a digital health application for cancer patients: a qualitative non-participation analysis.BMC health services research · 2024Article
- A qualitative interview study of patients' attitudes towards and intention to use digital interventions for depressive disorders on prescription.Frontiers in digital health · 2024Article
- Two years of approved digital health applications in Germany - Perspectives and experiences of general practitioners with an affinity for their use.The European journal of general practice · 2023Article
- [Evidence of positive care effects by digital health apps-methodological challenges and approaches].Innere Medizin (Heidelberg, Germany) · 2022Review
- One year of digital health applications (DiGA) in Germany - Rheumatologists' perspectives.Frontiers in medicine · 2022Article
- Opportunities and barriers for reimbursement of digital therapeutics in Austria: Findings From expert interviews.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since 2020 physicians can prescribe digital health applications (DiGA), also colloquially known as apps on prescription, which are reimbursed by the statutory health insurance when they are approved by the Federal Institute for Drugs and Medical Devices (BfArM) and are included in the DiGA Ordinance. Currently, there is one approved DiGA (indication obesity) for internal medicine. There are many questions on the practical use of the DiGA, ranging from the prescription, the effectiveness, the complexities and reimbursement as well as the liability risks. The DiGA are innovative new means, which maybe support internal medicine physicians in the diagnostics and treatment in the future. The benefits in this field of indications are limited by unclarified issues, especially on the prescription practice and the currently low number of DiGA available in internal medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.